| Type | Description |
|---|---|
| Definition | solute carrier family 25 member 5 |
| Date | Results | Publications |
|---|---|---|
| 2020-05-16 10:49:00 | ANT2 can be used as a marker of dedifferentiated pathology and aggressiveness of cancer. | 30225759 |
| 2017-07-01 13:03:00 | Findings suggest that ANT2 overexpression contributes to EGFR-TKI resistance in non-small cell lung cancer. | 26883272 |
| 2017-07-01 12:52:00 | Study found that ANT2 was upregulated in sorafenibresistant hepatocellular carcinoma Huh7 cell line and its overexpression promoted sorafenib resistance. | 28350139 |
| 2016-11-05 11:36:00 | cancer cells require both hANT2 and hANT3, depending on their proliferation status: hANT2 when proliferation rates are high, and hANT3 when proliferation slows. | 26842067 |
| 2016-10-22 11:58:00 | ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells. | 27012708 |
| Type | IDs |
|---|---|
| Synonymous | 2F1, AAC2, ANT2, T2, T3 |
| Gene |
UniProtKB-ID:
ADT2_HUMAN,
Q6NVC0_HUMAN
UniprotKB:
P05141,
Q6NVC0
UniParc:
UPI0000351553,
UPI000013C4ED
EMBL:
AK315292,
J02683,
L78810,
BC068199,
M57424,
BC056160,
J03591,
AC004000
Ensembl:
ENSG00000005022
KO:
hsa:292
|
| Nucleutide sequences |
EMBL-CDS:
AAA51737.1,
AAA36749.1,
AAA35579.1,
AAH56160.1,
AAB39266.1,
AAB96347.1,
BAG37698.1,
AAH68199.1
Ensembl_TRS:
ENST00000317881
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000360671
RefSeq:
NP_001143.2
|
| Others |
UniRef100:
UniRef100_P05141
UniRef90:
UniRef90_P05141
UniRef50:
UniRef50_P05141
UniGene:
Hs.632282
CCDS:
CCDS14578.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员